Hong Kong launches blueprint to guide choice between Chinese and Western medicine

Hong Kong health authorities will guide residents on when to seek Chinese medicine treatment, identifying conditions where it is considered more effective than Western practice, under a new blueprint for the sector's development. The initiative highlights the strengths of both medical traditions and aims to boost eHealth adoption among practitioners.

Hong Kong's government unveiled the city's first blueprint for Chinese medicine development on Thursday, outlining five key areas—services, profession, product development, culture, and global expansion—along with eight goals and 20 action plans.

Commissioner for Chinese Medicine Development Vincent Chung Chi-ho said on Saturday that only 9 per cent of the city's about 10,000 Chinese medicine practitioners were using eHealth, the government's electronic medical record platform. Authorities will step up efforts to promote its use in the sector.

Among the initiatives to enhance clinical services under the "Chinese Medicine Development Blueprint" is the formulation of a list of conditions in which Chinese medicine shows distinct advantages. Chung said Chinese and Western medicine each had their own strengths and residents should be guided on how to choose treatments effectively.

He gave the example of a stroke patient undergoing Chinese medicine rehabilitation after receiving Western treatment for the acute stage of the illness. The blueprint seeks to help residents make informed choices, emphasizing Chinese medicine's unique benefits in certain cases while advancing the profession's standardization and global reach.

संबंधित लेख

Former Hong Kong leader Leung Chun-ying launched a traditional Chinese medicine (TCM) trading platform on Thursday in Nansha, Guangdong province, to connect mainland Chinese manufacturers with international markets using Hong Kong's testing and certification systems. The Shouchuang platform, established under the TCM All-sector Hong Kong Centre founded by Leung in 2022, aims to promote centralisation, standardisation, marketisation and transparency in trade.

AI द्वारा रिपोर्ट किया गया

Hong Kong is recruiting for its Centre for Medical Products Regulation, expected to launch by the fourth quarter of 2026, as it seeks World Health Organization recognition and aims for independent drug approvals by 2030.

Hong Kong tourism chief Rosanna Law Shuk-pui said the city must become bigger and better rather than expect neighboring cities to stand still.

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें